159 related articles for article (PubMed ID: 24260303)
1. Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines.
Yamazaki H; Takagi S; Hoshino Y; Hosoya K; Okumura M
PLoS One; 2013; 8(11):e79810. PubMed ID: 24260303
[TBL] [Abstract][Full Text] [Related]
2. Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells.
Yamazaki H; Takagi S; Hosoya K; Okumura M
Vet J; 2015 Sep; 205(3):375-80. PubMed ID: 26048444
[TBL] [Abstract][Full Text] [Related]
3. Survivin suppressor (YM155) enhances chemotherapeutic efficacy against canine histiocytic sarcoma in murine transplantation models.
Yamazaki H; Takagi S; Hosoya K; Okumura M
Res Vet Sci; 2015 Apr; 99():137-44. PubMed ID: 25744435
[TBL] [Abstract][Full Text] [Related]
4. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
Zhu MM; Tong JL; Xu Q; Nie F; Xu XT; Xiao SD; Ran ZH
PLoS One; 2012; 7(8):e41763. PubMed ID: 22870247
[TBL] [Abstract][Full Text] [Related]
5. Survivin inhibition via EZN-3042 in canine lymphoma and osteosarcoma.
Shoeneman JK; Ehrhart EJ; Charles JB; Thamm DH
Vet Comp Oncol; 2016 Jun; 14(2):e45-57. PubMed ID: 24923332
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
7. Targeting MEK in a Translational Model of Histiocytic Sarcoma.
Takada M; Hix JML; Corner S; Schall PZ; Kiupel M; Yuzbasiyan-Gurkan V
Mol Cancer Ther; 2018 Nov; 17(11):2439-2450. PubMed ID: 30135215
[TBL] [Abstract][Full Text] [Related]
8. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
[TBL] [Abstract][Full Text] [Related]
9. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
[TBL] [Abstract][Full Text] [Related]
10. Impact of Co-transfection with Livin and survivin shRNA expression vectors on biological behavior of HepG2 cells.
Xu W; Chang H; Qin CK; Zhai YP
Asian Pac J Cancer Prev; 2013; 14(9):5467-72. PubMed ID: 24175843
[TBL] [Abstract][Full Text] [Related]
11. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
[TBL] [Abstract][Full Text] [Related]
12. Quantitative PCR and immunohistochemical analyses of HMGB1 and RAGE expression in canine disseminated histiocytic sarcoma (malignant histiocytosis).
Sterenczak KA; Kleinschmidt S; Wefstaedt P; Eberle N; Hewicker-Trautwein M; Bullerdiek J; Nolte I; Murua Escobar H
Anticancer Res; 2011 May; 31(5):1541-8. PubMed ID: 21617208
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
Chiu HW; Ho YS; Wang YJ
J Mol Med (Berl); 2011 Sep; 89(9):927-41. PubMed ID: 21594580
[TBL] [Abstract][Full Text] [Related]
14. Effect of survivin on tumor growth of colorectal cancer in vivo.
Cai Y; Ma W; Huang X; Cao L; Li H; Jiang Y; Lu N; Yin Y
Int J Clin Exp Pathol; 2015; 8(10):13267-72. PubMed ID: 26722528
[TBL] [Abstract][Full Text] [Related]
15. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.
Grossman D; McNiff JM; Li F; Altieri DC
J Invest Dermatol; 1999 Dec; 113(6):1076-81. PubMed ID: 10594755
[TBL] [Abstract][Full Text] [Related]
16. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
Sbiera S; Kroiss M; Thamm T; Beyer M; Majidi F; Kuehner D; Wobser M; Becker JC; Adam P; Ronchi C; Allolio B; Fassnacht M
Horm Metab Res; 2013 Feb; 45(2):137-46. PubMed ID: 23143666
[TBL] [Abstract][Full Text] [Related]
17. [The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549/DDP cells].
Wu Y; Guo L; Liu J; Liu R; Liu M; Chen J
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):1-7. PubMed ID: 24398307
[TBL] [Abstract][Full Text] [Related]
18. Optimization of photodynamic therapy response by survivin gene knockdown in human metastatic breast cancer T47D cells.
Cogno IS; Vittar NB; Lamberti MJ; Rivarola VA
J Photochem Photobiol B; 2011 Sep; 104(3):434-43. PubMed ID: 21641815
[TBL] [Abstract][Full Text] [Related]
19. Cinnamaldehyde derivative (CB-PIC) sensitizes chemo-resistant cancer cells to drug-induced apoptosis via suppression of MDR1 and its upstream STAT3 and AKT signalling.
Yun M; Lee D; Park MN; Kim EO; Sohn EJ; Kwon BM; Kim SH
Cell Physiol Biochem; 2015; 35(5):1821-30. PubMed ID: 25833196
[TBL] [Abstract][Full Text] [Related]
20. Persistent Morbillivirus Infection Leads to Altered Cortactin Distribution in Histiocytic Sarcoma Cells with Decreased Cellular Migration Capacity.
Pfankuche VM; Sayed-Ahmed M; Contioso VB; Spitzbarth I; Rohn K; Ulrich R; Deschl U; Kalkuhl A; Baumgärtner W; Puff C
PLoS One; 2016; 11(12):e0167517. PubMed ID: 27911942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]